Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the RESTART Survival Programme

NCT06283511 is registered in ClinicalTrials.gov with Jules Bordet Institute as lead sponsor.

NCT NCT06283511
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06283511 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the RESTART Survival Programme
Lead sponsor
Jules Bordet Institute
Phase
Observational
Overall status
Not yet recruiting
Start date
March 1, 2025
Completion date
December 31, 2026
Enrollment
200 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

invasive breast cancer